We are looking for 2–17 years of age to join a CD trial to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or moderately to severely active ulcerative colitis (including associated symptoms such as abdominal pain or cramping, loss of appetite, diarrhea, weight loss and/or joint pain), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing moderate to severe IBD flare-ups? Local CD trial is testing a potential new medication to see if it may reduce rectal pain, abdominal cramps, cramps, malnutrition, and/or eye pain associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children 2–17 years of age to join a Crohn’s disease study to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or Inflammatory bowel disease (including associated symptoms such as stomach pain, abdominal cramps, constant need to poop, frequent fevers and/or anemia), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local Crohn’s disease clinical trial is testing a potential new medication to see if it may reduce long-term diarrhea, perianal fistula, constant need to poop, weight loss, and/or liver disease associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the Crohn’s disease clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children 2–17 years of age to join a Crohn’s disease (CD) research study to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or moderate to severe Crohn’s disease (including associated symptoms such as fatigue, fatigue, diarrhea, frequent fevers and/or canker sores), consider one of our GI medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing Crohn’s disease flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce diarrhea with blood, failure to thrive, bloody stool, weight loss, and/or canker sores associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for 2–17 year olds to join a Crohn’s disease (CD) clinical research to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or IBD (including associated symptoms such as weight loss, perianal fistula, diarrhea, malnutrition and/or liver disease), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce swollen joints, mouth sores, bloody stool, chronic fatigue, and/or anemia associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for young people 2 to 17 years of age to join a Crohn’s disease (CD) medical research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderate to severe CD (including associated symptoms such as fever, perianal fistula, diarrhea, malnutrition and/or anemia), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing Crohn’s and UC flare-ups? Local medical research study is testing a potential new medication to see if it may reduce diarrhea with pus, iron deficiency, constant need to poop, malnutrition, and/or canker sores associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.